SEC Form 4 · accession 0001437749-15-014908
VBI VACCINES INC. · VBIV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Evander Anderson
Officer — Chief Scientific Officer
Period of report
Jul 30, 2015
Accepted (ET)
Aug 5, 2015 · 5:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000704159
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $2.56 | Jul 30, 2015 | A | 225,000 | A | — | Jul 30, 2025 | Common Stock | 225,000 | 682,304 | D |
Explanation of responses
- F1The option was issued from the VBI Vaccines Inc. 2014 Equity Incentive Plan. The right to purchase the option shares vests in equal increments over a period of 48 months, beginning on the date of grant.